器官來源：外周血
生長狀態(tài)：懸浮生長
數(shù)量：大量
運(yùn)輸方式：凍存運(yùn)輸
年限：19 years
細(xì)胞類型：T淋巴細(xì)胞
細(xì)胞形態(tài)：淋巴樣
是否是腫瘤細(xì)胞：0
物種來源：人
ATCC Number：CRL-1552?
相關(guān)疾病：白血病
規(guī)格：0.2ml Designations: MOLT-3
Depositors: ?J Minowada
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Homo sapiens
Morphology:lymphoblast
Source: Organ: peripheral blood
Disease: acute lymphoblastic leukemia
Cell Type: T lymphoblast;
Cellular Products:terminal deoxynucleotidyl transferase (TdT) activity is high [22735 ]
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Antigen Expression:CD1 (65%), CD4 (66%), CD5 (97%), CD7 (97%)
Cytogenetic Analysis:This is a hypertetraploid human cell line. The modal chromosome number was 97, occurring in 48% of cells. The rate of cells with higher ploidies was 2%. Three markers were common to all cells. They are: ?del(6) (q21), t(7;7), and an unidentifiable M5. The der(6) generally had three copies per cell, and the i(7q), two copies. The majority of normal chromosomes had 4 copies per cell. N8, N17, N19 and N20 had more than 4 copies in many cells. The X and Y chromosomes were two copies each per cell. Neither HSR chromosomes nor DM's were detected.
Isoenzymes: AK-1, 0
ES-D, 1
G6PD, B
GLO-I, 1
Me-2, 0
PGM1, 1
PGM3, 0
Age: 19 years
Gender: male
Comments:No immunoglobulin or Epstein-Barr virus is detectable. [22524 ]
This line was established from cells taken from a patient in relapse. [22524 ]
The patient had received prior multidrug chemotherapy. [22524 ]
MOLT-3 was derived from the same patient as the MOLT-4 cell line (ATCC CRL-1582 ). [22524 ]
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0°C
Subculturing: Protocol: Cultures are maintained by addition or replacement of fresh medium. Establish new cultures at 5 X 10(5) viable cells/ml and subculture at between 1 and 2 X 10(6) cells/ml.
Medium Renewal: Every 3 to 4 days
Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
recommended serum:ATCC 30-2020
derived from same individual:ATCC CRL-1582
References: 22524: Minowada J, et al. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst. 49: 891-895, 1972. PubMed: 4567231
22735: Mertelsmann R, et al. T-cell growth factor (interleukin 2) and terminal transferase activity in human leukemias and lymphoblastic cell lines. Blut 43: 99-103, 1981. PubMed: 6942897
